Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Trastuzumab-deruxtecan

Various toxicities

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Nonomiya Y, et al. Analysis of Adverse Events Associated with Trastuzumab Deruxtecan in Patients with Gastric and Breast Cancer: A Retrospective Study. Biological and Pharmaceutical Bulletin 47 : 411-416, No. 2, Jan 2024. Available from: URL: https://dx.doi.org/10.1248/bpb.b23-00695 Nonomiya Y, et al. Analysis of Adverse Events Associated with Trastuzumab Deruxtecan in Patients with Gastric and Breast Cancer: A Retrospective Study. Biological and Pharmaceutical Bulletin 47 : 411-416, No. 2, Jan 2024. Available from: URL: https://​dx.​doi.​org/​10.​1248/​bpb.​b23-00695
Metadaten
Titel
Trastuzumab-deruxtecan
Various toxicities
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-56615-8

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Pembrolizumab

Case report

Prednisolone

Case report

Imatinib

Case report

Antineoplastics